PRESS RELEASE published on 01/23/2025 at 18:37, 1 year 7 months ago Sword Group : Résultats du 4ème trimestre 2024 Sword Group affiche une croissance organique de +17,1% et une rentabilité de 12,0% au 4T 2024. Trésorerie nette en hausse de +20M€ et carnet de commandes en augmentation record de +78M€ Rentabilité Croissance Organique Trésorerie Nette Carnet De Commandes Sword Group
BRIEF published on 01/02/2025 at 07:35, 1 year 8 months ago Sword Group lance son plan d'affaires pour 2028 Cybersécurité Intelligence Artificielle Croissance Stratégique Plan D'affaires 2028 Philippe Blanche Directeur Financier
BRIEF published on 01/02/2025 at 07:35, 1 year 8 months ago Sword Group Initiates Business Plan 2028 Artificial Intelligence Cybersecurity Strategic Growth Business Plan 2028 Philippe Blanche CFO
PRESS RELEASE published on 01/02/2025 at 07:30, 1 year 8 months ago Sword Group: Launch of Business Plan 2028 Sword Group announces the launch of its ambitious 2028 Business Plan focusing on growth strategies and key areas for development. New Group CFO appointed for enhanced governance and financial controls Group CFO Growth Strategies Sword Group 2028 Business Plan Key Areas
BRIEF published on 09/02/2024 at 07:35, 2 years ago Acquisition stratégique de Sword Group en Suisse Alémanique Acquisition Transformation Digitale Sword Group INCOR Suisse Alémanique
BRIEF published on 09/02/2024 at 07:35, 2 years ago Strategic acquisition of Sword Group in German-speaking Switzerland Acquisition Digital Transformation Sword Group INCOR German-speaking Switzerland
PRESS RELEASE published on 09/02/2024 at 07:30, 2 years ago Sword Group : 1er pas en Suisse Alémanique Le Groupe Sword fait son premier pas en Suisse Alémanique en acquérant INCOR, spécialisée en Transformation Digitale. Consolidation des comptes dès juillet 2024 Acquisition Transformation Digitale Sword Group Suisse Alémanique Incorporation
BRIEF published on 08/30/2024 at 17:40, 2 years ago Sword Group: Availability of the 2024 Half-Year Financial Report Financial Report Luxembourg Stock Exchange Sword Group CSSF Half-yearly 2024
BRIEF published on 08/30/2024 at 17:40, 2 years ago Sword Group : Mise à disposition du Rapport Financier Semestriel 2024 Rapport Financier Bourse De Luxembourg Sword Group CSSF Semestriel 2024
PRESS RELEASE published on 08/30/2024 at 17:35, 2 years ago Sword Group : Bilan semestriel du Contrat de Liquidité contracté avec la société ODDO BHF Sword Group annonce les résultats du Contrat de Liquidité avec ODDO BHF pour le premier semestre 2024 conformément à la Décision de l’AMF n° 2018-01 Contrat De Liquidité AMF ODDO BHF Résultats Sword Group
Published on 09/11/2026 at 04:00, 6 hours 46 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 21 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 26 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 46 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 31 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 26 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 41 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 46 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 46 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 46 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 46 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 16 minutes ago Availability of the 2026 Interim Financial Report
